Humana Inc
NYSE:HUM

  • LAST PRICE
    339.5800
  • TODAY'S CHANGE (%)
    3.9900 (1.1890%)
  • Bid / Lots
    334.2200/ 1
  • Ask / Lots
    345.0000/ 1
  • Open / Previous Close
    335.4100 / 335.5900
  • Day Range
    335.4100
    344.6400
  • 52 Week Range
    298.6063
    530.5399
  • Volume
    1,852,771

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Today

      Show headlines and story abstract

    • 1 hour ago by MT Newswires
      Companies Mentioned: HUM
      04:54 PM EDT, 05/13/2024 (MT Newswires) -- Humana (HUM) said late Monday that Jim Rechtin will take over as its president and chief executive officer from July 1, 2024. The company had previously announced that Rechtin joined as president and chief...

    • 2 hours ago by Business Wire
      Companies Mentioned: HUM

      Leading health insurer and health care services company Humana Inc. (NYSE: HUM) announced today that Jim Rechtin will assume the role of President and Chief Executive Officer effective July 1, 2024. As previously announced, Rechtin joined Humana as President and Chief Operating Officer in January as part of a long-planned CEO transition. Since then, he has worked in close partnership with Humana's current CEO, Bruce Broussard, and has immersed himself in Humana's operations to help shape the company's future strategic direction and make it easier for the millions of people Humana serves to achieve their best health.

    • 2 hours ago by Dow Jones
      Companies Mentioned: HUM
      LOUISVILLE, Ky.--(BUSINESS WIRE)--May 13, 2024--
      Leading health insurer and health care services company Humana Inc. (NYSE: HUM) announced today that Jim Rechtin will assume the role of President and Chief Executive Officer effective July 1, 2024. As previously announced, Rechtin joined Humana as President and Chief Operating Officer in January as part of a long-planned CEO transition. Since then, he has worked in close partnership with Humana's current CEO, Bruce Broussard, and has immersed himself in Humana's operations to help shape the company's future strategic direction and make it easier for the millions of people Humana serves to achieve their best health.

  • May 9, 2024

      Show headlines and story abstract

    • 9:16AM ET on Thursday May 09, 2024 by GlobeNewswire
      Companies Mentioned: HUM, ADUS, HCA, BKD, EHAB

    • 9:15AM ET on Thursday May 09, 2024 by Dow Jones
      Companies Mentioned: HUM, ADUS, ELV, HCA, BKD, EHAB

      As of the date hereof, AREX Capital Master directly beneficially owns 549,277 shares of common stock, par value $0.01 per share, of the Company (the "Common Stock") and has economic exposure to an aggregate of 54,782 notional shares of Common Stock pursuant to certain cash-settled total return swap agreements. Each of AREX Capital Partners and AREX Limited, as feeder funds of AREX Capital Master, may be deemed to beneficially own the 549,277 shares of Common Stock owned by AREX Capital Master. AREX Capital GP, as the general partner of AREX Capital Master, may be deemed to beneficially own the 549,277 shares of Common Stock owned by AREX Capital Master. AREX Capital Management, as the investment advisor of each of AREX Capital Master and certain accounts separately managed by AREX Capital Management (the "AREX Managed Accounts"), may be deemed to beneficially own the 2,425,809 shares of Common Stock owned in the aggregate by AREX Capital Master and held in the AREX Managed Accounts. AREX Capital Management GP, as the general partner of AREX Capital Management, may be deemed to beneficially own the 2,425,809 shares of Common Stock owned in the aggregate by AREX Capital Master and held in the AREX Managed Accounts. Mr. Rechtschaffen, as the Managing Member of each of AREX Capital GP and AREX Capital Management GP, may be deemed to beneficially own the 2,425,809 shares of Common Stock owned in the aggregate by AREX Capital Master and held in the AREX Managed Accounts. As of the date hereof, none of Mses. Ambers, Hochhauser nor O'Neal, nor Messrs. Corcoran, Ohlendorf nor Vallarino, nor Dr. Sheff own any shares of Common Stock.

Peers Headlines